acquired
Stage
About
NeoMend developed advanced biomedical and medical device technologies focused on tissue repair and healing, and was acquired by C.R. Bard, Inc.
Explore NeoMend's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.